PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Dermatologic Unit, Department of Specialized Medicine, AOU Policlinico di Modena, Modena, Italy.\', \'Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.\', \'Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.\', \'Department of Pharmaceutical and Pharmacological Sciences, PhD Degree Program in Pharmacological Sciences, University of Padua, Padua, Italy.\', \'Dermatology Unit, Surgical, Medical, and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.\', \'Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.\', \'Dermatology Clinic, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/dth.15088
?:hasPublicationType
?:journal
  • Dermatologic therapy
is ?:pmid of
?:pmid
?:pmid
  • 34355846
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.625
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Switching infliximab in psoriatic patients during COVID-19 pandemics: A real-life retrospective study comparing intra-versus interclass switching strategies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all